In this model, MTE treatment activates PTEN signaling, which inhibits PI3K/AKT/mTOR signaling, antagonizes the PI3K/AKT/mTOR anti-apoptotic pathway, meanwhile inhibits the cell proliferation in T-ALL cells. Here, AKT1 is linked to acute lymphoblastic leukemia.